Global Bone Marrow Transplant Market is Expected to be Worth US$ 13,750.7 Million and Have 121,661 Procedures Performed By The End of 2027

Bone Marrow Transplant

Bone marrow is a vascularized soft tissue found inside long bones. There are two types of stem cells in this system: hematopoietic and mesenchymal stem cells. Hematopoiesis (the formation of blood cells), lymphocyte production, and fat storage are all carried out by bone marrow.

These benefits include a faster onset and offset of action, predictable pharmacokinetics, and fewer drug interactions, all of which eliminate the need for regular coagulation monitoring that is required with traditional anticoagulant therapy. The Bone Marrow Transplant Market is being fueled by an increase in government spending, an increase in the incidence rate of venous thromboembolism, an increase in patient awareness about treatment, and high unmet needs of current treatment options. However, the disease's complex pathophysiology, high treatment costs, and associated side effects are key restraints for the venous thromboembolism market.

Furthermore, rising advancements in stem cell cryopreservation are expected to contribute to market growth over the forecast period. In 2018, the European region dominated the Global Bone Marrow Transplant Market, accounting for 58.5 percent of the total value, followed by North America. Researchers from Harbin Institute of Technology, for example, developed a comprehensive process for determining the membrane transport properties of Jurkat cells, an immortalized line of human acute lymphocyte leukaemia cells that is widely used in the study of adoptive cell therapy, in the study 'Determination of the Membrane Transport Properties of Jurkat Cells with a Microfluidic Device' published in November 2019. 

Restraints in the Global Bone Marrow Transplant Market

The global Bone Marrow Transplant Market is expected to be hampered by a lack of reimbursement policies for organ transplantation procedures in emerging economies. Furthermore, the high cost of a bone marrow transplant is expected to stifle market growth. In Europe and the United States, the cost of a single autologous transplant ranges from US$ 30,000 to US$ 88,000, with a matched unrelated myeloablative allogeneic procedure costing US$ 200,000 or more. The global market for bone marrow transplant leukaemia treatment type segment was worth US$ 2,382.6 million in 2018, and is expected to grow at a CAGR of 3.5 percent to US$ 3,260.5 million by 2027.